Searching... Searching...
  • NVP + NA
  • Köp NA
  • Sälj NA
  • Senast NA
  • SEK

  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Company presentations


NeuroVive’s research currently covers four segments where the company’s in-depth mitochondrial know-how has the potential to make a substantial improvement to care: Genetic Mitochondrial Diseases, Traumatic Brain Injury (TBI), Non-Alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma (HCC).

NeuroVive Capital Markets Day, 9 October, 2019

Stockholm Corporate Finance 11th Life Science seminar, on 13 – 14 March 2019.

Aktiedagen Lund 2019, 29 January

Stora Aktiedagen Stockholm 2018, 26 November

Analysts' lunch at Cord Communications in Stockholm, 22 November 2018.

The LSX Inv€$tival Showcase and the Jefferies 2018 Healthcare Conference, 13 – 15 November

Finwire.Tv – NeuroVive Sitdown – interview with CEO Erik Kinnman

Aktiespararna – Kvinnokvällen, Gothenburg

15 October 2018. Chief Financial Officer & Vice President Investor Relations Catharina Johansson and CEO Erik Kinnman presneted the company.

LSX Nordic Congress, Stockholm

30 August 2018

NeuroVive's presentation at BioStock Live in Lund, 18 April 2018

Financial Hearings' interview with CEO Erik Kinnman

2nd Annual H.C. Wainwright NASH Investor Conference, New York, 19 March 2018

Live webcast at 11.20 local time

Stockholm Corporate Finance Life Science Seminarium, 7 March 2018

NeuroVive at Aktiedagen in Lund, 30 January 2018

 10th Annual Conference – Biotech Showcase 2018, San Francisco

8 January 2018 at 4:00 p.m. local time (PST), 9 January 2018 at 1:00 a.m. Swedish time (CET). Registration required.

Executive interview by EdisonTV

CEO Erik Kinnman presents at the 2017 Biotech and Money Inv€$tival Showcase Conference in London

Mitochondria Day, 19 September 2017, Stockholm, Sweden

Börsveckans Småbolagsdag, 23 August 2017, Stockholm, Sweden

Mitochondrial Medicine Focus Drives NeuroVive Orphan Ambitions

Interview with CEO Erik Kinnman, Scrip Pharma intelligence, 18 May 2017

Aktiespararna's Aktiedag Stockholm, 15 May 2017

View CEO Erik Kinnman's presentation here:

Web cast on in-licensing agreement with Yungjin Pharm, 3 May 2017, at 2:00 pm CEST

Erik Kinnman, CEO, and Magnus Hansson, CMO, will be presenting and will be available for questions after the presentation.


9th Annual Conference – Biotech Showcase 2017, San Francisco

10 January 2017 at 5:00 p.m. local time (PST), 11 January 2017 at 2:00 a.m. Swedish time (CET). Registration required.


Stora Aktiedagen, 28 November 2016, Stockholm, Sweden

View CEO Erik Kinnman's presentation here:



Webcast for presentation of the CiPRICS study results
October 13, 2016 at 3.00 p.m. CEST.

To call in please use one of the following numbers: Sweden: +46856642690 UK: +442030089815 US: +18558315946.

Rodman & Renshaw 18th Annual Global Investment Conference
September 13, 2016 at 5:05 p.m. EDT /11:05 p.m. CEST.


NeuroVive's presentation at BioStock Live Roadshow, 20 April (In Swedish)





Comments are closed.

IR Contact

Catharina Johansson


+46 (0) 46-275 62 21